Clinical trial
Drug Therapy for Generalized Anxiety Disorder Among the Elderly
NCT00105586 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00105586 |
|---|---|
| Title | Drug Therapy for Generalized Anxiety Disorder Among the Elderly |
| Official title | Pharmacotherapy of Late-Life Generalized Anxiety Disorder |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anxiety Disorders, Generalized Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Escitalopram |
| Enrollment | 177 |
| Start date | Dec 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 16, 2005 |
| Last update posted | May 8, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: